Form4insider filings, from the source

Insider holders · CIK 0001100412

ARRAY BIOPHARMA INC · ARRY

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Jeremy Green10% Owner—16,658,07216,658,072Sep 30, 2016 · 3:55 pm EDTForm 4
Redmile Group, LLC10% Owner—16,658,07216,658,072Sep 30, 2016 · 3:55 pm EDTForm 4
Ron SquarerCEO238,709—238,709Feb 8, 2019 · 6:31 pm ESTForm 4
Victor SandorChief Medical Officer228,998—228,998Jan 2, 2019 · 4:32 pm ESTForm 4
Nicholas A SaccomanoCSO142,488—142,488Feb 8, 2019 · 6:32 pm ESTForm 4
Andrew R RobbinsCOO59,994—59,994Feb 8, 2019 · 6:36 pm ESTForm 4
John R MooreVP, General Counsel40,102—40,102Apr 6, 2017 · 8:30 pm EDTForm 4/A
Kyle LefkoffDirector22,72015,00037,720Feb 8, 2019 · 7:14 pm ESTForm 4
Jason HaddockCFO30,059—30,059Feb 8, 2019 · 6:34 pm ESTForm 4
Gil J Van LunsenDirector24,297—24,297Oct 29, 2018 · 6:10 pm EDTForm 4
Curtis Gale OltmansGeneral Counsel15,021—15,021Feb 7, 2019 · 4:30 pm ESTForm 4
Charles M BaumDirector15,000—15,000Oct 29, 2018 · 6:09 pm EDTForm 4
Gwen A. FyfeDirector15,000—15,000Oct 29, 2018 · 6:09 pm EDTForm 4
John A OrwinDirector15,000—15,000Oct 29, 2018 · 6:10 pm EDTForm 4
Carrie Smith CoxDirector8,000—8,000Feb 21, 2019 · 4:30 pm ESTForm 4
David SnitmanCOO and VP, Business Devel.7,477—7,477Mar 4, 2015 · 8:12 pm ESTForm 4
Shalini SharpDirector5,000—5,000Oct 29, 2018 · 6:10 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.